Skip to main content
LMMY logo

LMMY · Exousia Bio, Inc. · Financials

Track LMMY — free
$0.01 At close · Nov 11
Market Cap
$635,250
Shares
52.50M
Volume · Nov 11 14.18K Avg daily vol (3M) 84.51K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$3750 -67.4%
FY2025 Revenue FY2023–FY2025
Net Income
$51.4K +299.2%
FY2025 Net Income FY2023–FY2025
Gross Margin
-93.36% -109.3pp
FY2025 Gross Margin FY2024–FY2025
Diluted EPS
$0.00
FY2025 Diluted EPS FY2023–FY2025
Operating Cash Flow
-$4528 +63.7%
FY2025 Operating Cash Flow FY2023–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023
$3750 $11.5K $0
$7251 $9667 $0
-$3501 $1833 $0
-93.36% 15.94% —
$28.38K $28.08K $56.42K
$31.84K $28.08K $56.42K
— — -$56.42K
$86.74K $436 $0
$51.4K -$25.81K -$56.42K
$0 $0 $0
$51.4K -$25.81K -$56.42K
1370.53% -224.41% —
USD/shares $0.00 $0.00 $0.00
USD/shares $0.00 $0.00 $0.00
shares 7.78M 7.78M 5.69M
shares 7.78M 7.78M 5.69M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Other notes payable 2026-02-28 USD 0 10-Q filed 2026-06-16
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 0.24×
EV/EBIT
—
P/E (TTM)
—
Price/Sales (TTM)
—
Peer median 0.38×
Price/Book
0.03×
Peer median 0.37×

Peer medians compare against the 11 similar-size Education & Training Services companies (of 47 listed).

Valuation over time computed as of each quarter's filing date

Key facts CIK 1939937 CUSIP 50172J105 Visit website Investor relations